Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review

Purpose: To describe the outcome of a patient with a rare primitive uterine pPNET and to perform a review of the available data in literature, leading the clinicians to better face this rare disease. Methods: We have rescued data regarding the multidisciplinary treatment of pPNET from the PUBMED database, highlighting also issues regarding the pathogenesis and the genetic landscape of the ESFTs (Ewing Sarcoma Family of Tumors). Results: Ewing sarcoma and primitive neuroectodermal tumors (PNETs) are small round cell tumors presenting with different degrees of neuroectodermal differentiation. PNETs are further divided into central PNET and peripheral PNET (pPNET). Since pPNETs share the same genetic background of Ewing Sarcomas, they are considered to belong to the Ewing Sarcoma Family of Tumors (ESFTs). Multimodality treatment currently represents the best choice to offer to the affected patients. Conclusion: Although pPNETs are generally diagnosed in children and young adults, an elderly woman aged 85 years came to our attention after a diagnosis of uterine pPNET. Her medical history is presented here, along with a literature review of the subject, highlighting the main biological, pathological and clinical features, with a hypothesis about the possible future therapeutic approaches for these rare malignancies.

[1]  P. Houghton,et al.  Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force , 2019, F1000Research.

[2]  G. Nicholas,et al.  Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors , 2017, Case Reports in Oncology.

[3]  Yong-Koo Park,et al.  Ewing sarcoma: a chronicle of molecular pathogenesis. , 2016, Human pathology.

[4]  A. Llombart‐Bosch,et al.  Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. , 2016, Annals of diagnostic pathology.

[5]  S. Lessnick,et al.  Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting , 2016, Oncotarget.

[6]  C. Fletcher,et al.  Round cell sarcomas - biologically important refinements in subclassification. , 2014, The international journal of biochemistry & cell biology.

[7]  M. Sharma,et al.  Outcomes and prognostic factors for Ewing-family tumors of the extremities. , 2014, The Journal of bone and joint surgery. American volume.

[8]  C. Antonescu Round cell sarcomas beyond Ewing: emerging entities , 2014, Histopathology.

[9]  Abha A. Gupta,et al.  Optimal Management of Ewing Sarcoma Family of Tumors: Recent Developments in Systemic Therapy , 2013, Pediatric Drugs.

[10]  D. Osuna,et al.  Advances in Ewing's sarcoma research: where are we now and what lies ahead? , 2009, Cancer research.

[11]  A. Lazar,et al.  Ewing’s Sarcoma: Standard and Experimental Treatment Options , 2009, Current treatment options in oncology.

[12]  K. Laschinger,et al.  Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship. , 2008, Clinical journal of oncology nursing.

[13]  E. Ademoglu,et al.  Ewing sarcoma in a geriatric patient , 2005, Aging clinical and experimental research.

[14]  J. Khoury Ewing Sarcoma Family of Tumors , 2005, Advances in anatomic pathology.

[15]  Hiroshi Kobayashi,et al.  [Soft tissue sarcoma: postoperative chemotherapy]. , 2004, Gan to kagaku ryoho. Cancer & chemotherapy.

[16]  C. Roberts,et al.  The insulin-like growth factor system and cancer. , 2003, Cancer letters.

[17]  X. Shu,et al.  Insulin-like growth factors and breast cancer risk in Chinese women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  Christopher T Denny,et al.  Biology of EWS/ETS fusions in Ewing's family tumors , 2001, Oncogene.

[19]  M. Raffeld,et al.  Molecular Confirmation of Ewing Sarcoma , 2001, Journal of pediatric hematology/oncology.

[20]  J. Pelletier,et al.  Molecular genetics of chromosome translocations involving EWS and related family members. , 1999, Physiological genomics.

[21]  F. Gudat,et al.  Molecular Diagnosis of Ewing Tumors: Improved Detection of EWS‐FLI‐1 and EWS‐ERG Chimeric Transcripts and Rapid Determination of Exon Combinations , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[22]  G. Thomas,et al.  Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors. , 1997, Cancer genetics and cytogenetics.

[23]  P. Lollini,et al.  Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. , 1996, Cancer research.

[24]  C. Denny,et al.  The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.

[25]  D. Yee,et al.  Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. , 1990, The Journal of clinical investigation.

[26]  R. Heyn The role of chemotherapy in the management of soft tissue sarcomas , 1975, Cancer.

[27]  H. Gelderblom,et al.  Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway. , 2016, European journal of cancer.

[28]  D. Ranchère‐Vince,et al.  [Ewing/PNET sarcoma family of tumors: towards a new paradigm?]. , 2015, Annales de pathologie.

[29]  Wen-Qi Jiang,et al.  [Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy]. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[30]  B. Seddon,et al.  Emerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma , 2008, Paediatric drugs.

[31]  C. Denny,et al.  Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor. , 1997, Current topics in microbiology and immunology.